The dose for Evenity is two prefilled syringes that will be administered by a healthcare professional once every month for 12 months. They are both given as a subcutaneous injection. The most ...

Amgen and UCB finally have FDA approval for osteoporosis drug Evenity, two years after it was turned down by the regulator because of safety concerns. The agency approved Evenity (romosozumab ...

Amgen and UCB have resubmitted their application for US approval of Evenity as an osteoporosis treatment, hoping that the additional data they have provided will help overcome the FDA’s previous ...